Health Secretary Robert F. Kennedy Jr. has appointed eight new members to the advisory immunization committee, including vaccine opponents, The Wall Street Journal’s Liz Essley Whyte and Dominique Mosbergen report. The new panel will review both new and existing vaccine recommendations. Kennedy’s move came two days after abruptly removing all 17 of the prior members of the Advisory Committee on Immunization Practices. “All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense,” RFK Jr. said. Publicly traded companies in the pharmaceutical and vaccine space include Moderna (MRNA), Novavax (NVAX), BioNTech (BNTX), AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderately bullish activity in Moderna with shares up 3.03%
- SPY ETF News, 6/11/2025
- Mixed options sentiment in Moderna with shares down 0.78%
- Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
- RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members